On ECHEMI
Home > Drugs > Levofloxacin Lactate Injection

Levofloxacin Lactate Injection

Function and Efficacy

This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and inhibit bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, gonococci, etc. It also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.

Ingredients

Main ingredients and chemical name of this product: The main ingredient of this product is levofloxacin lactate, and its chemical name is: (S)-(-)-9-fluoro-2-,3-dihydro-3-methyl-10(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de][1,4]-benzoxazine-6-carboxylic acid lactate hemihydrate. [Molecular formula] C18H20FN3O4C3H6O31/2H2O [Molecular weight] 460.41

Name Description Content CAS NO. Manufacturer
LEVOFLOXACIN LACTATEIngredients

This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and inhibit bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, and gonococci; it also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.

More
294662-18-3 11

Indication

It is suitable for moderate to severe respiratory system, urinary system, digestive system and skin and soft tissue infections caused by sensitive strains of Gram-negative bacteria and Gram-positive bacteria, sepsis, typhoid and paratyphoid dysentery, and urethritis and cervicitis caused by gonococci and Chlamydia trachomatis.

Usage and Dosage

Intravenous drip: Adults: 0.1-0.2g at a time, twice a day, or as directed by a doctor.

Adverse Reactions

Poor appetite, nausea, vomiting, diarrhea, insomnia, dizziness, headache, rash, elevated serum alanine aminotransferase and local irritation symptoms after injection may occur occasionally, but they are generally tolerated and disappear after the treatment.

Precautions

It is contraindicated for people who are allergic to quinolones and patients with epilepsy. [Use in pregnant and lactating women] It is contraindicated for pregnant and lactating women. [Use in children] It is contraindicated for patients under 18 years old.

Drug Interactions

Not yet clear.

Storage

Keep away from light and store in a sealed container.

Packaging Specification

2ml: 0.1g

Manufacturer

Jiangsu Lianshui Pharmaceutical Co., Ltd.

  • Founded in:

    1999-05-21
  • Address:

    No. 18, Hongri Avenue, Lianshui Economic Development Zone
  • Tax NO.:

    91320826139830519D
  • Registered Funds:

    80 million yuan
  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.